Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Mj Uitdehaag

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 14, 2016
Evaluation of the Multiple Sclerosis Walking Scale-12 (MSWS-12) in a Dutch sample: Application of item response theoryLidwine Brigitta Mokkink, Francisca Galindo-Garre, Bernard Mj Uitdehaag
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 10, 2018
Development of the Arm Function in Multiple Sclerosis Questionnaire-Short Form (AMSQ-SF): A static 10-item versionMichiel Aj Luijten, Iris Eekhout, Marie D'Hooghe, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 22, 2016
Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up studyAxel Petzold, Martijn D Steenwijk, Judith M Eikelenboom, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 19, 2019
Minimal clinically important difference of improvement on the Arm Function in Multiple Sclerosis Questionnaire (AMSQ)Caspar Ep van Munster, Levent Kaya, Morgan Obura, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 18, 2017
Retinal atrophy in relation to visual functioning and vision-related quality of life in patients with multiple sclerosisLisanne J Balk, Danko Coric, Jenny A Nij Bijvank, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 29, 2019
Leveraging real-world data to investigate multiple sclerosis disease behavior, prognosis, and treatmentJeffrey A Cohen, Maria Trojano, Ellen M Mowry, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 25, 2022
The MSIS-29 and SF-36 as outcomes in secondary progressive MS trialsEva Mm Strijbis, Pavle Repovic, Jop Mostert, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 26, 2019
Infusion-related events during natalizumab: No need for post-infusion monitoringFloor C Loonstra, Johannis A van Rossum, Zoé LE van Kempen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 24, 2017
Natalizumab-associated progressive multifocal leukoencephalopathy is not preceded by elevated drug concentrationsZoé LE van Kempen, Cyra E Leurs, Anke Vennegoor, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2017
Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layersDanko Coric, Lisanne J Balk, Merike Verrijp, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 14, 2016
Evaluation of the Multiple Sclerosis Walking Scale-12 (MSWS-12) in a Dutch sample: Application of item response theoryLidwine Brigitta Mokkink, Francisca Galindo-Garre, Bernard Mj Uitdehaag
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 10, 2018
Development of the Arm Function in Multiple Sclerosis Questionnaire-Short Form (AMSQ-SF): A static 10-item versionMichiel Aj Luijten, Iris Eekhout, Marie D'Hooghe, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 22, 2016
Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up studyAxel Petzold, Martijn D Steenwijk, Judith M Eikelenboom, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 19, 2019
Minimal clinically important difference of improvement on the Arm Function in Multiple Sclerosis Questionnaire (AMSQ)Caspar Ep van Munster, Levent Kaya, Morgan Obura, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 18, 2017
Retinal atrophy in relation to visual functioning and vision-related quality of life in patients with multiple sclerosisLisanne J Balk, Danko Coric, Jenny A Nij Bijvank, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 29, 2019
Leveraging real-world data to investigate multiple sclerosis disease behavior, prognosis, and treatmentJeffrey A Cohen, Maria Trojano, Ellen M Mowry, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 25, 2022
The MSIS-29 and SF-36 as outcomes in secondary progressive MS trialsEva Mm Strijbis, Pavle Repovic, Jop Mostert, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 26, 2019
Infusion-related events during natalizumab: No need for post-infusion monitoringFloor C Loonstra, Johannis A van Rossum, Zoé LE van Kempen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 24, 2017
Natalizumab-associated progressive multifocal leukoencephalopathy is not preceded by elevated drug concentrationsZoé LE van Kempen, Cyra E Leurs, Anke Vennegoor, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2017
Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layersDanko Coric, Lisanne J Balk, Merike Verrijp, et al.
Pageof 5